Big biotech, Biotech, Partnering

Bavarian Nordic awarded $228m for vaccine industry research

Posted on 23 April 2013

Tags: , , ,

Bavarian Nordic, a big biotech company,  won a two-year, $228 million U.S. government award for a smallpox vaccine industry research that accounts for almost all the company’s revenue.

Hedegaard had warned that the company might fire hundreds of workers and shut down a factory in Denmark if the Department of Health and Human Services didn’t order the work.

Bavarian Nordic’s Imvamune vaccine is meant for people with atopic dermatitis and compromised immune systems.

They are at risk of severe adverse reactions to the regular smallpox vaccine.

The new industry research award will ensure the U.S. has a total of 20 million doses of Bavarian Nordic’s smallpox vaccine in stock in case of a public health emergency.

Bavarian Nordic is guaranteed to receive $110 million for 4 million doses of its Imvamune vaccine.

The remaining $118 million, for another 4 million doses, hinges on the availability of U.S. funding next year, company officials said during the call.

For further deal information visit Current Agreements (subscription required)


Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Report: Infectives Partnering Terms and Agreements

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View:Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View:Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View:Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup:Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup:Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe:Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on:LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply